Drug intelligence / Profile preview

terbinafine + fluconazole

Development stage
Preclinical
Lead developer
Chattogram Medical College
Modality
Small Molecules
Administration
Oral
01

Overview

terbinafine + fluconazole is an investigational oral antifungal combination regimen being evaluated for the treatment of refractory dermatophytosis (fungal skin infections such as tinea corporis and tinea cruris). The combination consists of two small-molecule antifungal agents with complementary mechanisms of action targeting the fungal ergosterol biosynthesis pathway. Terbinafine is an allylamine antifungal that inhibits squalene epoxidase, preventing the conversion of squalene to lanosterol, while fluconazole is a triazole antifungal that inhibits lanosterol 14-alpha-demethylase (CYP51). By targeting different steps of the same biosynthetic pathway, the combination aims to achieve synergistic fungicidal activity and overcome treatment resistance. The regimen is being evaluated in clinical trials sponsored by Chittagong Medical College.

Other names
fluconazole + terbinafineterbinafine and fluconazoleterbinafine/fluconazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)SQLE (Squalene monooxygenase)

Beyond the preview

Go deeper on terbinafine + fluconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terbinafine + fluconazole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call